Health Care Law News and Insights

DOJ Takes Aim At Telehealth And Genetic Testing Markets

Published: Oct 08, 2019
|
The U.S. Department of Justice (DOJ) continues to actively target the healthcare industry for False Claims Act (FCA) and other alleged violations, and it took significant steps to further its reach into the telehealth and genetic testing markets this week. Prosecutors in the Southern District of Florida (SDFL) indicted the...

Read More

Short-Term Government Funding Legislation Includes Health Policy Extenders, Drug Rebate Definition Change, DSH Policies

Published: Oct 04, 2019
|
On September 26, 2019 the Senate approved H.R. 4378, the Continuing Appropriations Act, 2020, and Health Extenders Act of 2019, which would fund the federal government through November 21, 2019. The House has already approved the legislation, and President Trump is expected to sign the bill. The legislation includes a number...

Read More

Compounding Pharmacy And Private Equity Firm Owner Agree To $21 Million Settlement To Resolve FCA Allegations

Published: Sep 26, 2019
|
By
The Department of Justice (DOJ) recently announced that it has agreed to a $21.36 million settlement with compounding pharmacy Diabetic Care Rx LLC d/b/a Patient Care America (PCA), private equity firm Riordan, Lewis & Haden Inc. (RLH), and two PCA executives to resolve a pending False Claims Act (FCA) case. As discussed...

Read More
Go to Top